Beyond Monoamines: Glutamatergic Function in Mood Disorders
The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Abstract
The monoamine theory has implicated abnormalities in serotonin and norepinephrine in the pathophysiology of major depression and bipolar illness and contributed greatly to our understanding of mood disorders and their treatment. Nevertheless, some limitations of this model still exist that require researchers and clinicians to seek further explanation and develop novel interventions that reach beyond the confines of the monoaminergic systems. Recent studies have provided strong evidence that glutamate and other amino acid neurotransmitters are involved in the pathophysiology and treatment of mood disorders. Studies employing in vivo magnetic resonance spectroscopy have revealed altered cortical glutamate levels in depressed subjects. Consistent with a model of excessive glutamate-induced excitation in mood disorders, several antiglutamatergic agents, such as riluzole and lamotrigine, have demonstrated potential antidepressant efficacy. Glial cell abnormalities commonly associated with mood disorders may at least partly account for the impairment in glutamate action since glial cells play a primary role in synaptic glutamate removal. A hypothetical model of altered glutamatergic function in mood disorders is proposed in conjunction with potential antidepressant mechanisms of antiglutamatergic agents. Further studies elucidating the role of the glutamatergic system in the pathophysiology of mood and anxiety disorders and studies exploring the efficacy and mechanism of action of antiglutamatergic agents in these disorders, are likely to provide new targets for the development of novel antidepressant agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A synaptic model of memory: long-term potentiation in the hippocampus
Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,658
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477
Glia: listening and talking to the synapse
Haydon, P. G. (2001) · Nature Reviews Neuroscience · doi:10.1038/35058528 · Cited by 1,408
Tariot, P. N., Farlow, M. R., Grossberg, G. T., Graham, S. M., McDonald, S., Gergel, I., & for the Memantine Study Group (2004) · JAMA · doi:10.1001/jama.291.3.317 · Cited by 1,403
Control of Synapse Number by Glia
Ullian, E. M., Sapperstein, S. K., Christopherson, K. S., & Barres, B. A. (2001) · Science · doi:10.1126/science.291.5504.657 · Cited by 1,380
Pathways to neuronal injury and apoptosis in HIV-associated dementia
Kaul, M., Garden, G. A., & Lipton, S. A. (2001) · Nature · doi:10.1038/35073667 · Cited by 1,210
Neuropsychopharmacology: The Fifth Generation of Progress
SAGDUYU, K. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1251-a · Cited by 1,019
Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats
Moghaddam, B., & Adams, B. W. (1998) · Science · doi:10.1126/science.281.5381.1349 · Cited by 1,006
Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression
Sanacora, G., Gueorguieva, R., Epperson, C. N., Wu, Y.-T., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796
Self-citationFunctional antagonists at the NMDA receptor complex exhibit antidepressant actions
Trullas, R., & Skolnick, P. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90204-j · Cited by 785
Cotter, D., Mackay, D., Landau, S., Kerwin, R., & Everall, I. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.545 · Cited by 766
Mathur, R. (2004) · Drug Screening Methods · doi:10.5005/jp/books/10243_6 · Cited by 665
Bowden, C. L. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.4.392 · Cited by 658
Sanacora, G., Mason, G. F., Rothman, D. L., Behar, K. L., Hyder, F., Petroff, O. A. C., Berman, R. M., Charney, D. S., & Krystal, J. H. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.11.1043 · Cited by 627
Self-citationChronic inhibition of glutamate uptake produces a model of slow neurotoxicity.
Rothstein, J. D., Jin, L., Dykes-Hoberg, M., & Kuncl, R. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6591 · Cited by 623
The Yin and Yang of NMDA receptor signalling
Hardingham, G. E., & Bading, H. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)00040-1 · Cited by 620
Rajkowska, G., Halaris, A., & Selemon, L. D. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01080-0 · Cited by 570
Auer, D. P., Pütz, B., Kraft, E., Lipinski, B., Schill, J., & Holsboer, F. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00159-6 · Cited by 564
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
Krystal, J. H., Sanacora, G., Blumberg, H., Anand, A., Charney, D. S., Marek, G., Epperson, C. N., Goddard, A., & Mason, G. F. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001021 · Cited by 553
Self-citationIncreased Cortical GABA Concentrations in Depressed Patients Receiving ECT
Sanacora, G., Mason, G. F., Rothman, D. L., Hyder, F., Ciarcia, J. J., Ostroff, R. B., Berman, R. M., & Krystal, J. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.577 · Cited by 513
Self-citationLow glial numbers in the amygdala in major depressive disorder
Bowley, M. P., Drevets, W. C., Öngür, D., & Price, J. L. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01404-x · Cited by 503
Calabrese, J. R., Suppes, T., Bowden, C. L., Sachs, G. S., Swann, A. C., McElroy, S. L., Kusumakar, V., Ascher, J. A., Earl, N. L., Greene, P. L., et al. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1106 · Cited by 498
Sanacora, G., Mason, G. F., Rothman, D. L., & Krystal, J. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.4.663 · Cited by 494
Self-citationNakagawa, S., Kim, J.-E., Lee, R., Malberg, J. E., Chen, J., Steffen, C., Zhang, Y.-J., Nestler, E. J., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03673.2002 · Cited by 485
Brain Metabolic Alterations in Medication-Free Patients With BipolarDisorder
Dager, S. R., Friedman, S. D., Parow, A., Demopulos, C., Stoll, A. L., Lyoo, I. K., Dunner, D. L., & Renshaw, P. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.5.450 · Cited by 453
A Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood Disorders
Frye, M. A., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Speer, A. M., Osuch, E. A., Luckenbaugh, D. A., Corá-Locatelli, G., Leverich, G. S., & Post, R. M. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00004 · Cited by 446
Anand, A., Charney, D. S., Oren, D. A., Berman, R. M., Hu, X. S., Cappiello, A., & Krystal, J. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.270 · Cited by 426
Woo, T.-U. W., Walsh, J. P., & Benes, F. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.649 · Cited by 411
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs
Shigeri, Y., Seal, R. P., & Shimamoto, K. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.04.004 · Cited by 391
Kodama, M., Fujioka, T., & Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.008 · Cited by 387
Heninger, G., Delgado, P., & Charney, D. (1996) · Pharmacopsychiatry · doi:10.1055/s-2007-979535 · Cited by 380
Lebon, V., Petersen, K. F., Cline, G. W., Shen, J., Mason, G. F., Dufour, S., Behar, K. L., Shulman, G. I., & Rothman, D. L. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01523.2002 · Cited by 371
Antidepressants for the new millennium
Skolnick, P. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00330-1 · Cited by 355
Miguel-Hidalgo, J. J., Baucom, C., Dilley, G., Overholser, J. C., Meltzer, H. Y., Stockmeier, C. A., & Rajkowska, G. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00999-9 · Cited by 336
An Open-Label Trial of Riluzole in Patients With Treatment-Resistant Major Depression
Zarate, C. A., Payne, J. L., Quiroz, J., Sporn, J., Denicoff, K. K., Luckenbaugh, D., Charney, D. S., & Manji, H. K. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.171 · Cited by 324
Heckers, S., Stone, D., Walsh, J., Shick, J., Koul, P., & Benes, F. M. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.521 · Cited by 322
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Tatarczyńska, E., Kłodzińska, A., Chojnacka‐Wójcik, E., Pałucha, A., Gasparini, F., Kuhn, R., & Pilc, A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703923 · Cited by 314
d-Cycloserine: A ligand for the coupled glycine receptor has partial agonist characteristics
Hood, W. F., Compton, R. P., & Monahan, J. B. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90379-0 · Cited by 308
Regulation of Adult Neurogenesis by Psychotropic Drugs and Stress
Duman, R. S., Malberg, J., & Nakagawa, S. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29244-2 · Cited by 300
Hossein Fatemi, S., Stary, J. M., Earle, J. A., Araghi-Niknam, M., & Eagan, E. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.02.017 · Cited by 300
Papp, M., & Moryl, E. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90516-9 · Cited by 272
Krystal, J. H., Abi-Saab, W., Perry, E., D’Souza, D. C., Liu, N., Gueorguieva, R., McDougall, L., Hunsberger, T., Belger, A., Levine, L., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-004-1982-8 · Cited by 272
Alterations of neuroplasticity in depression: the hippocampus and beyond
Fuchs, E., Czéh, B., Kole, M. H. P., Michaelis, T., & Lucassen, P. J. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.09.002 · Cited by 269
Si, X., Miguel-Hidalgo, J. J., O'Dwyer, G., Stockmeier, C. A., & Rajkowska, G. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300525 · Cited by 268
Nowak, G., Ordway, G. A., & Paul, I. A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00057-w · Cited by 262
Novel Neurotransmitters and Their Neuropsychiatric Relevance
Snyder, S. H., & Ferris, C. D. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1738 · Cited by 262
Zarate, C. A., Quiroz, J. A., Singh, J. B., Denicoff, K. D., De Jesus, G., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.023 · Cited by 257
Chaki, S., Yoshikawa, R., Hirota, S., Shimazaki, T., Maeda, M., Kawashima, N., Yoshimizu, T., Yasuhara, A., Sakagami, K., Okuyama, S., et al. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.10.009 · Cited by 254
ROSENBERG, D. R., MIRZA, Y., RUSSELL, A., TANG, J., SMITH, J. M., BANERJEE, S. P., BHANDARI, R., ROSE, M., IVEY, J., BOYD, C., et al. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000132812.44664.2d · Cited by 246
Plasma and platelet excitatory amino acids in psychiatric disorders
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.11.1731 · Cited by 243
(1965) · The Lancet · doi:10.1016/s0140-6736(65)91538-2 · Cited by 236
Mauri, M. C., Ferrara, A., Boscati, L., Bravin, S., Zamberlan, F., Alecci, M., & Invernizzi, G. (1998) · Neuropsychobiology · doi:10.1159/000026491 · Cited by 231
Bhagwagar, Z., Wylezinska, M., Taylor, M., Jezzard, P., Matthews, P. M., & Cowen, P. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.368 · Cited by 227
Antidepressant-like actions of an AMPA receptor potentiator (LY392098)
Li, X., Tizzano, J. P., Griffey, K., Clay, M., Lindstrom, T., & Skolnick, P. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00194-5 · Cited by 225
Review of the Use of Topiramate for Treatment of Bipolar Disorders
Suppes, T. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200212000-00010 · Cited by 215
Riluzole Enhances Glutamate Uptake in Rat Astrocyte Cultures
Frizzo, M. E. D. S., Dall'Onder, L. P., Dalcin, K. B., & Souza, D. O. (2004) · Cellular and Molecular Neurobiology · doi:10.1023/b:cemn.0000012717.37839.07 · Cited by 212
Vanhoutte, P., & Bading, H. (2003) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(03)00073-4 · Cited by 210
Michael, N., Erfurth, A., Ohrmann, P., Arolt, V., Heindel, W., & Pfleiderer, B. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300085 · Cited by 208
Neuronal Glutamate Uptake Contributes to GABA Synthesis and Inhibitory Synaptic Strength
Mathews, G. C., & Diamond, J. S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02040.2003 · Cited by 204
Nacher, J., Rosell, D. R., Alonso‐Llosa, G., & McEwen, B. S. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01424.x · Cited by 200
Prolonged effect of an anesthetic dose of ketamine on behavioral despair
Yilmaz, A., Schulz, D., Aksoy, A., & Canbeyli, R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00693-1 · Cited by 199
Increased serum glutamate in depressed patients
Kim, J. S., Schmid-Burgk, W., Claus, D., & Kornhuber, H. H. (1982) · Archiv f�r Psychiatrie und Nervenkrankheiten · doi:10.1007/bf00345492 · Cited by 189
Small-Dose Ketamine Improves the Postoperative State of Depressed Patients
Kudoh, A., Takahira, Y., Katagai, H., & Takazawa, T. (2002) · Anesthesia & Analgesia · doi:10.1097/00000539-200207000-00020 · Cited by 189
Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations.
Castillo, M., Kwock, L., Courvoisie, H. E., & Hooper, S. R. (2000) · PubMed · Cited by 187
Nacher, J., Alonso-Llosa, G., Rosell, D. R., & McEwen, B. S. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00096-9 · Cited by 186
Rosa, A. O., Lin, J., Calixto, J. B., Santos, A. R. S., & Rodrigues, A. L. S. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00069-x · Cited by 183
Yang, C.-H., Huang, C.-C., & Hsu, K.-S. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0406-05.2005 · Cited by 181
Maes, M., Verkerk, R., Vandoolaeghe, E., Lin, A., & Scharpé, S. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10004.x · Cited by 179
Richards, F. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90780-4 · Cited by 176
Nowak, G., Szewczyk, B., Wieronska, J. M., Branski, P., Palucha, A., Pilc, A., Sadlik, K., & Piekoszewski, W. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00104-7 · Cited by 171
Barbosa, L., Berk, M., & Vorster, M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0407 · Cited by 165
ZARATE, C. A., DU, J., QUIROZ, J., GRAY, N. A., DENICOFF, K. D., SINGH, J., CHARNEY, D. S., & MANJI, H. K. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.017 · Cited by 164
Antidepressants plus benzodiazepines for major depression
Furukawa, T. A., Streiner, D., Young, L. T., & Kinoshita, Y. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001026 · Cited by 161
Antidepressant-like properties of zinc in rodent forced swim test
Kroczka, B., Branski, P., Palucha, A., Pilc, A., & Nowak, G. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00473-7 · Cited by 161
Clinical Studies Implementing Glutamate Neurotransmission in Mood Disorders
SANACORA, G., ROTHMAN, D. L., MASON, G., & KRYSTAL, J. H. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.018 · Cited by 157
Self-citationMultiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats
Pilc, A., Kłodzińska, A., Brański, P., Nowak, G., Pałucha, A., Szewczyk, B., Tatarczyńska, E., Chojnacka-Wójcik, E., & Wierońska, J. M. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00082-5 · Cited by 150
Effects of MK-801 and antidepressant drugs in the forced swimming test in rats
Maj, J., Rogóż, Z., Skuza, G., & Sowińska, H. (1992) · European Neuropsychopharmacology · doi:10.1016/0924-977x(92)90034-6 · Cited by 150
Nudmamud‐Thanoi, S., & Reynolds, G. P. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.09.035 · Cited by 150
GABA and glutamate systems as therapeutic targets in depression and mood disorders
Kendell, S. F., Krystal, J. H., & Sanacora, G. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.1.153 · Cited by 150
Self-citationBenzodiazepines as antidepressants: Does GABA play a role in depression?
Petty, F., Trivedi, M. H., Fulton, M., & Rush, A. J. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00049-7 · Cited by 146
Reduced Anterior Cingulate Cortex Glutamatergic Concentrations in Childhood Major Depression
Mirza, Y., Tang, J., Russell, A., Banerjee, S. P., Bhandari, R. P., Ivey, J., Rose, M., Moore, G. J., & Rosenberg, D. R. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200403000-00017 · Cited by 141
Current perspectives on the development of non-biogenic amine-based antidepressants
Skolnick, P., Legutko, B., Li, X., & Bymaster, F. P. (2001) · Pharmacological Research · doi:10.1006/phrs.2000.0806 · Cited by 139
An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study
Maćkowiak, M., O’Neill, M. J., Hicks, C. A., Bleakman, D., & Skolnick, P. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00066-7 · Cited by 139
Benzodiazepines in Depressive Disorders
Schatzberg, A. F. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770350085008 · Cited by 137
Coric, V., Milanovic, S. M., Wasylink, S., Patel, P., Malison, R. T., & Krystal, J. H. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1396-z · Cited by 136
Impairment of GABAergic Transmission in Depression: New Insights from Neuroimaging Studies
Sanacora, G., Mason, G. F., & Krystal, J. H. (2000) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v14.i1.20 · Cited by 132
Self-citationMind Glue: Implications of Glial Cell Biology for Psychiatry
COYLE, J. T., & Schwarcz, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.90 · Cited by 129
CYLOSERINE AS AN ANTIDEPRESSANT AGENT
CRANE, G. E. (1959) · American Journal of Psychiatry · doi:10.1176/ajp.115.11.1025 · Cited by 127
Chapter 21 Glutamate toxicity in chronic neurodegenerative disease
Lancelot, E., & Beal, M. F. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)60446-x · Cited by 123
Görtelmeyer, R., & Erbler, H. C. (1992) · PubMed · Cited by 121
Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder
Scarr, E., Pavey, G., Sundram, S., MacKinnon, A., & Dean, B. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00024.x · Cited by 120
Przegaliński, E., Tatarczynska, E., Dereń-Wesołek, A., & Chojnacka-Wójcik, E. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(96)00157-8 · Cited by 117
Involvement of the sigma1 receptor in the modulation of dopaminergic transmission by amantadine
Peeters, M., Romieu, P., Maurice, T., Su, T., Maloteaux, J., & Hermans, E. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03297.x · Cited by 115
Mundo, E., Tharmalingham, S., Neves-Pereira, M., Dalton, E. J., Macciardi, F. M., Parikh, S. V., Bolonna, A. A., Kerwin, R. W., Arranz, M. J., MAKOFF, A. J., et al. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001218 · Cited by 114
Legutko, B., Li, X., & Skolnick, P. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00006-5 · Cited by 112
Rosenthal, M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1016 · Cited by 110
1-Aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models
Trullás, R., Folio, T., Young, A., Miller, R. L., Boje, K. M. K., & Skolnick, P. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90894-v · Cited by 108
A high prevalence of organ-specific autoimmunity in patients with bipolar disorder
Padmos, R. C., Bekris, L. M., Knijff, E. M., Tiemeier, H. W., Kupka, R., Cohen, D., Nolen, W. A., Lernmark, Å., & Drexhage, H. A. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.003 · Cited by 108
Lamotrigine as Adjunct to Paroxetine in Acute Depression: A Placebo-Controlled, Double-Blind Study
Normann, C., Hummel, B., Scharer, L. O., Horn, M., Grunze, H., & Walden, J. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0411 · Cited by 107
Zinc exhibits an antidepressant-like effect in the forced swimming test in mice.
Kroczka, B., Zieba, A., Dudek, D., Pilc, A., & Nowak, G. (2000) · PubMed · Cited by 105
Obrocea, G. V., Dunn, R. M., Frye, M. A., Ketter, T. A., Luckenbaugh, D. A., Leverich, G. S., Speer, A. M., Osuch, E. A., Jajodia, K., & Post, R. M. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01206-9 · Cited by 105
Amantadine as augmentation therapy in the management of treatment-resistant depression
Stryjer, R., Strous, R. D., Shaked, G., Bar, F., Feldman, B., Kotler, M., Polak, L., Rosenzcwaig, S., & Weizman, A. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200303000-00005 · Cited by 103
Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats
Meloni, D., Gambarana, C., Montis, M. G. D., Pra, P. D., Taddei, I., & Tagliamonte, A. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90374-3 · Cited by 100
Lamotrigine as an Augmentation Agent in Treatment-Resistant Depression
Barbee, J. G., & Jamhour, N. J. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0813 · Cited by 97
Possible Use of Amantadine in Depression
Huber, T., Dietrich, D., & Emrich, H. (1999) · Pharmacopsychiatry · doi:10.1055/s-2007-979191 · Cited by 97
Francis, P. T., Poynton, A., Lowe, S. L., Najlerahim, A., Bridges, P. K., Bartlett, J. R., PROCTER, A. W., Bruton, C. J., & Bowen, D. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)90600-8 · Cited by 96
LY404187: A Novel Positive Allosteric Modulator of AMPA Receptors
Quirk, J. C., & Nisenbaum, E. S. (2002) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2002.tb00228.x · Cited by 93
Interaction of zinc with antidepressants in the forced swimming test in mice.
Szewczyk, B., Brański, P., Wierońska, J. M., Pałucha-Poniewiera, A., Pilc, A., & Nowak, G. (2002) · PubMed · Cited by 90
Antidepressant Effect of Ketamine During ECT
Ostroff, R. B., GONZALES, M., & Sanacora, G. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1385 · Cited by 89
Self-citationMindham, R. H. S., MARSDEN, C. D., & Parkes, J. D. (1976) · Psychological Medicine · doi:10.1017/s0033291700007467 · Cited by 87
Low nNOS protein in the locus coeruleus in major depression
Karolewicz, B., Szebeni, K., Stockmeier, C. A., Konick, L., Overholser, J. C., Jurjus, G., Roth, B. L., & Ordway, G. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02792.x · Cited by 84
Elevated Levels of the NR2C Subunit of the NMDA Receptor in the Locus Coeruleus in Depression
Karolewicz, B., Stockmeier, C. A., & Ordway, G. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300781 · Cited by 81
Tiagabine in treatment refractory bipolar disorder: a clinical case series
Suppes, T. M., Chisholm, K., Dhavale, D. M., Frye, M. A., Altshuler, L. L., McElroy, S. L., Keck, P. E., Nolen, W. A., Kupka, R., Denicoff, K. D., et al. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01201.x · Cited by 78
Maj, J., Rogóż, Z., Skuza, G., & Sowińska, H. (1992) · PubMed · Cited by 78
Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology
Quiroz, J. A., Singh, J. B., Gould, T. D., Denicoff, K. D., Zarate, C. A., & Manji, H. K. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001521 · Cited by 75
Neurochemistry of late‐life major depression: A pilot two‐dimensional MR spectroscopic study
Binesh, N., Kumar, A., Hwang, S., Mintz, J., & Thomas, M. A. (2004) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20214 · Cited by 72
Riluzole Augmentation for Treatment-Resistant Depression
Sanacora, G., Kendell, S. F., Fenton, L. R., Coric, V., & Krystal, J. H. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2132 · Cited by 72
Self-citationAffinity of 1-aminoadamantanes for the σ binding site in post-mortem human frontal cortex
Kornhuber, J., Schoppmeyer, K., & Riederer, P. F. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90362-o · Cited by 71
Valproate as an antidepressant in major depressive disorder.
Davis, L. L., Kabel, D., Patel, D., Choate, A., Foslien-Nash, C., Gurguis, G. N. M., Kramer, G. L., & Petty, F. (1996) · PubMed · Cited by 69
Vale, S., Espejel, M. A., & Dominguez, J. C. (1971) · The Lancet · doi:10.1016/s0140-6736(71)90153-x · Cited by 64
MK-801 and enantiomers: Potential antidepressants or false positives in classical screening models?
Panconi, E., Roux, J., Altenbaumer, M., Hampe, S., & Porsolt, R. D. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90310-p · Cited by 62
Wierońska, J. M., Szewczyk, B., Brański, P., Pałucha-Poniewiera, A., & Pilc, A. (2002) · Amino Acids · doi:10.1007/s00726-001-0131-5 · Cited by 59
The psychotropic effects of cycloserine: A new use for an antibiotic
Crane, G. E. (1961) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(61)80007-2 · Cited by 58
Selective Inhibition of Calcium Entry Induced by Benzylisoquinolines in Rat Smooth Muscle
Anselmi, E., Fayos, G., Blasco, R., Candenas, L., Cortés, D., & D’Ocón, P. (1992) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1992.tb03617.x · Cited by 56
Papp, M., & Moryl, E. (1993) · PubMed · Cited by 51
Diffusional extrasynaptic neurotransmission via glutamate and GABA
Semyanov, A. V. (2005) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-005-0051-z · Cited by 49
Ambrozi, L., & Danielczyk, W. (1988) · Pharmacopsychiatry · doi:10.1055/s-2007-1014666 · Cited by 49
Ferszt, R., Kühl, K.-P., Bode, L., Severus, E., Winzer, B., Berghöfer, A., Beelitz, G., Brodhun, B., Müller-Oerlinghausen, B., & Ludwig, H. (1999) · Pharmacopsychiatry · doi:10.1055/s-2007-979220 · Cited by 49
Lamotrigine augmentation in unipolar depression
Rocha, F. L., & Hara, C. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200303000-00006 · Cited by 49
Xi, Z., Shen, H., Baker, D. L., & Kalivas, P. W. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02093.x · Cited by 48
Liu, T. P., Liu, I. M., TSAI, C.-C., Lai, T.-H., Hsu, F.-L., & Cheng, J. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021778835 · Cited by 42
Lamotrigine in the treatment of bipolar disorder
Bowden, C. L. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.10.1513 · Cited by 42
Farvolden, P., Kennedy, S. H., & Lam, R. W. M. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.1.65 · Cited by 41
Effects of Trimebutine Maleate on Delayed Rectifier K+ Currents in Guinea-pig Ventricular Myocytes
Morisawa, T., Hasegawa, J., Tanabe, K., Watanabe, A., Kitano, M., & Kishimoto, Y. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001774156 · Cited by 41
The effect of NMDA antagonists on footshock-induced fighting behavior in chronically stressed rats.
Ossowska, G., Klenk-Majewska, B., & Szymczyk, G. (1997) · PubMed · Cited by 38
Novel treatments for bipolar disorder
Bowden, C. L. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.4.661 · Cited by 36
Adjunctive Lamotrigine Treatment for Major Depression
MALTESE, T. M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1833 · Cited by 30
Is Diazepam an Antidepressant?
Tiller, J. W. G., Schweitzer, I., Maguire, K. P., & Davies, B. (1989) · The British Journal of Psychiatry · doi:10.1192/bjp.155.4.483 · Cited by 30
Is diazepam an antidepressant?
Tiller, J. W. G., Davies, B., Schweitzer, I., & Maguire, K. P. (1990) · The British Journal of Psychiatry · doi:10.1192/bjp.157.1.149a · Cited by 23
Glial Pathology in Major Psychiatric Disorders
Cotter, D., Pariante, C. M., & Rajkowska, G. (2002) · Neurobiological foundation of aberrant behaviors · doi:10.1007/978-1-4757-3631-1_5 · Cited by 22
Petty, F., Kramer, G. L., & Hendrickse, W. A. (1993) · Springer eBooks · doi:10.1007/978-1-4757-9498-4_4 · Cited by 20
Wyska, E., Szymura‐Oleksiak, J., Opoka, W., Baś, B., Niewiara, E., Pomierny-Chamioło, L., Dybała, M., & Nowak, G. (2004) · PubMed · Cited by 9
Treatment-refractory depression: Definitions and characteristics
Berman, R. M., Narasimhan, M., & Charney, D. S. (1997) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1997)5:4<154::aid-da2>3.0.co;2-d
Cited by
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894
Self-citationThe immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
Müller, N., & Schwarz, M. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002006 · Cited by 670
Glutamate and Neurotrophic Factors in Neuronal Plasticity and Disease
Mattson, M. P. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1418.005 · Cited by 640
Gliogenesis and Glial Pathology in Depression
Rajkowska, G., & Miguel-Hidalgo, J. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780619326 · Cited by 610
Metadata
- Authors
- Kugaya, A., & Sanacora, G.
- Venue
- CNS Spectrums
- Publisher
- Cambridge University Press (CUP)
- Published
- 2005-10
- Volume
- 10
- Issue
- 10
- Pages
- 808-819
- ISSN
- 1092-8529 (ISSN-L)
- 2165-6509
- OpenAlex
- W1928141651
- Cited by
- 290
- References
- 150
- FWCI
- 10.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.